Who We Are
Light Line Medical Inc.’s patented visible-light platform technology is an infection prevention game-changer, destined to create a massive global shift in how the world prevents and treats heath care associated infections. The CDC reported that each year over 2 million people in the United States are infected by antibiotic resistant bacteria and over 23,000 people die from the infections . Without relying on drugs, chemicals, or UV light, visible light technology is the first antimicrobial for all infections, including antibiotic resistant bacteria, which the CDC has identified as “one of the world’s most pressing public health threats” .
Light Line Medical has four revolutionary systems in development. The Light Line Dialysis and Light Line Foley Catheters will be launched first, followed by the Light Line Respiratory and Light Line Vascular Catheters. Our phototherapy system uses non-UV visible light (violet/blue) to disinfect catheters, reduce and treat bacteria, and prevent biofilm, all of which cause peritoneal dialysis and hemodialysis infections, urinary tract infections, bloodstream infections, and ventilator associated pneumonia.
Results show a dramatic reduction in bacteria between control and light treated groups. SEM images from in vitro testing of Light Line's prototype Foley catheter show the extraluminal contrast in bacteria growth between test and control groups.
- Antibiotic/Antimicrobial Resistance. Cdc.gov. https://www.cdc.gov/drugresistance/index.html. Updated March 29, 2018. Access May 2, 2018.
- Antibiotic Resistant Threats in the United States, 2013. Cdc.gov. https://cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf. Accessed May 2, 2018.